Good Manufacturing Practice (GMP) is the foundation of quality and regulatory compliance in the healthcare manufacturing industry. For clinicians, pharmacists, and suppliers, GMP assures that medicines and therapeutic goods are produced under consistent and controlled conditions.
This article examines GMP principles, their significance in healthcare and medicinal cannabis, and how tools like The Compendium facilitate more informed decision-making.
Good Manufacturing Practice (GMP) is a set of manufacturing standards designed to ensure products are consistently produced and controlled to established quality benchmarks. These guidelines cover all aspects of production, from raw materials to final packaging.
Importantly, GMP is not a single test at the end of production. It requires quality to be built into every step through validated processes, clear documentation, and strict oversight. In Australia, the Therapeutic Goods Administration (TGA) oversees GMP compliance for medicines and other regulated products.
The TGA highlights that GMP helps safeguard the integrity of therapeutic goods. Some key principles include:
Together, these measures form part of a broader Quality Management System (QMS).
In Australia, medicine manufacturers must hold a licence and demonstrate GMP compliance through TGA inspections. Overseas suppliers importing into Australia also need to show GMP certification that meets acceptable standards.
For medicinal cannabis, requirements are equally strict. Producers need appropriate licences under the Therapeutic Goods Act 1989 and, if relevant, under the Narcotic Drugs Act 1967. Imported products must come from facilities that meet approved GMP standards.
Failure to comply can result in enforcement actions, such as recalls or restrictions on supply.
GMP is part of a broader quality framework. A Quality Management System (QMS) is a structured set of processes and controls designed to support consistent manufacturing outcomes and compliance with regulatory requirements (TGA).
Manufacturers use a QMS to ensure processes are documented, controlled, and continually reviewed in line with applicable standards (TGA). Key elements of a QMS include:
A QMS helps maintain consistency across product design, manufacturing, and distribution. It also supports structured change-control and validation protocols when adjustments are required.
Accurate recordkeeping is essential in GMP environments. Good Documentation Practice (GDocP) refers to requirements that records be complete, legible, contemporaneous, and securely maintained (PharmOut).
In practice, this involves following the ALCOA+ principles:
These principles ensure records are reliable and accessible for audits and regulatory reviews.
GMP forms part of the broader family of GxP practices, which also includes:
Each framework focuses on maintaining quality and compliance in different parts of the product lifecycle (Microsoft Learn). Collectively, GxP standards provide a structured approach to ensuring processes meet regulatory expectations.
For clinicians, pharmacists, and suppliers, GMP compliance supports confidence in prescribing and dispensing decisions.
While GMP does not guarantee outcomes for individual patients, it provides the framework for consistent product quality across the industry.
Good Manufacturing Practice (GMP) underpins trust in therapeutic goods by ensuring consistent quality and regulatory compliance. For those working in medicinal cannabis, GMP is a key requirement that shapes every step of the supply chain.
Platforms like The Compendium give healthcare professionals structured access to essential product information, including compliance details and stock visibility. This helps clinicians, pharmacists, and suppliers make timely, informed decisions while supporting high standards across the sector.
GMP forms part of the broader family of GxP practices, which also includes:
Each framework focuses on maintaining quality and compliance in different parts of the product lifecycle (Microsoft Learn). Collectively, GxP standards provide a structured approach to ensuring processes meet regulatory expectations.
“*” indicates required fields
PRIVACY COLLECTION NOTICE
This Privacy Collection Notice describes how PHENIX HEALTH PTY LTD (ABN 22 607 822 266) (we, us or our) collects and handles your personal information when you make an enquiry with us. We collect personal information from you so that we can respond to your enquiry and for related purposes set out in our Privacy Policy, available on our website (or on request).
We may disclose this personal information to third parties, including our personnel, related entities, any third parties engaged by us and acting on our behalf and as otherwise set out in our Privacy Policy.
We store personal information in Australia. Where we disclose your personal information to third parties, those third parties may store, transfer or access personal information outside of Australia.
If you do not provide your personal information to us, it may affect our ability to do business with you.
Please see our Privacy Policy for more information about how we collect, store, use and disclose your personal information, including details about overseas disclosure, access, correction, how you can make a privacy-related complaint and our complaint-handling process.
If you have questions about our privacy practices, please contact us by email at: info@thecompendium.health. By providing your personal information to us, you agree to the collection, use, storage and disclosure of that information as described in this privacy collection notice.